Oral IRAK-4 inhibitor CA-4948 is blood-brain barrier penetrant and has single-agent activity against CNS lymphoma and melanoma brain metastases
Article in Clinical Cancer Research (February 2023)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (February 2023)
Article in Cureus (October 2022)
Preprint in medRxiv (June 2022)